These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2399513)

  • 1. [Pharmacokinetics of dexamethasone administered orally in obese patients].
    Lamiable D; Vistelle R; Sulmont V; Millart H; Caron J; Choisy H
    Therapie; 1990; 45(4):311-4. PubMed ID: 2399513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.
    Cheymol G; Weissenburger J; Poirier JM; Gellee C
    Br J Clin Pharmacol; 1995 Jun; 39(6):684-7. PubMed ID: 7654489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of sufentanil in obese patients.
    Schwartz AE; Matteo RS; Ornstein E; Young WL; Myers KJ
    Anesth Analg; 1991 Dec; 73(6):790-3. PubMed ID: 1835321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect.
    Varis T; Kivistö KT; Backman JT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R; Nabriski D; Apovian CM; Niven M; Weiss E; Shapiro MS; Shenkman L
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of continuous positive airway pressure therapy on hypothalamic-pituitary-adrenal axis function and 24-h blood pressure profile in obese men with obstructive sleep apnea syndrome.
    Carneiro G; Togeiro SM; Hayashi LF; Ribeiro-Filho FF; Ribeiro AB; Tufik S; Zanella MT
    Am J Physiol Endocrinol Metab; 2008 Aug; 295(2):E380-4. PubMed ID: 18523125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive weight loss decreases corticosteroid-binding globulin levels and increases free cortisol in healthy obese patients: an adaptive phenomenon?
    Manco M; Fernández-Real JM; Valera-Mora ME; Déchaud H; Nanni G; Tondolo V; Calvani M; Castagneto M; Pugeat M; Mingrone G
    Diabetes Care; 2007 Jun; 30(6):1494-500. PubMed ID: 17526821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of aprepitant and dexamethasone in the prevention of chemotherapy-induced nausea and vomiting.
    Nakade S; Ohno T; Kitagawa J; Hashimoto Y; Katayama M; Awata H; Kodama Y; Miyata Y
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):75-83. PubMed ID: 18317761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex difference in the relationship between the hypothalamic-pituitary-adrenal axis and sex hormones in obesity.
    Vicennati V; Ceroni L; Genghini S; Patton L; Pagotto U; Pasquali R
    Obesity (Silver Spring); 2006 Feb; 14(2):235-43. PubMed ID: 16571848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal function following high-dose steroids in ovarian cancer patients.
    Del Priore G; Gurski KJ; Warshal DP; Angel C; Dubeshter B
    Gynecol Oncol; 1995 Oct; 59(1):102-4. PubMed ID: 7557593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Gn-RH, TRH, and CRF administration on plasma leptin levels in lean and obese women.
    Komorowski J; Jankiewicz-Wika J; Stepień H
    Neuropeptides; 2000 Apr; 34(2):89-97. PubMed ID: 10985925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity of the hypothalamic-pituitary-adrenal system of pigeons (Columba livia domestica) to suppression by dexamethasone, cortisol, and prednisolone.
    Westerhof I; Van den Brom WE; Mol JA; Lumeij JT; Rijnberk A
    Avian Dis; 1994; 38(3):435-45. PubMed ID: 7832695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased cortisol bioavailability, abdominal obesity, and the metabolic syndrome in obese women.
    Duclos M; Marquez Pereira P; Barat P; Gatta B; Roger P
    Obes Res; 2005 Jul; 13(7):1157-66. PubMed ID: 16076984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Value of determining dexamethasone in the rapid adrenal suppression test].
    Lamiable D; Sulmont V; Millart H; Delemer B; Caron J; Choisy H
    Ann Endocrinol (Paris); 1989; 50(1):44-8. PubMed ID: 2729881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics of low-dose dexamethasone in congenital adrenal hyperplasia.
    Young MC; Cook N; Read GF; Hughes IA
    Eur J Clin Pharmacol; 1989; 37(1):75-7. PubMed ID: 2591468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronopharmacokinetics of dexamethasone in young subjects].
    Lamiable D; Vistelle R; Fay R; Millart H; Caron J; Choisy H
    Therapie; 1991; 46(5):405-7. PubMed ID: 1754989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of oral and intramuscular administration of dexamethasone in late pregnancy.
    Elliott CL; Read GF; Wallace EM
    Acta Obstet Gynecol Scand; 1996 Mar; 75(3):213-6. PubMed ID: 8607331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics of intravenous propranolol in obese and normal volunteers.
    Cheymol G; Poirier JM; Barre J; Pradalier A; Dry J
    J Clin Pharmacol; 1987 Nov; 27(11):874-9. PubMed ID: 3429695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dexamethasone bovine pharmacokinetics.
    Gaignage P; Lognay G; Bosson D; Vertongen D; Dreze P; Marlier M; Severin M
    Eur J Drug Metab Pharmacokinet; 1991; 16(3):219-21. PubMed ID: 1814739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone pharmacokinetics after high-dose oral therapy for pemphigus.
    Tóth GG; Westerlaken BO; Eilders M; Laseur M; Jonkman MF; Uges DR
    Ann Pharmacother; 2002 Jun; 36(6):1108-9. PubMed ID: 12058710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.